银行综合授信
Search documents
联创光电: 关于公司增加2025年度银行综合授信额度的公告
Zheng Quan Zhi Xing· 2025-05-09 09:01
证券代码:600363 股票简称:联创光电 编号:2025-042 江西联创光电科技股份有限公司 关于公司增加 2025 年度银行综合授信额度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 为保证公司生产经营和业务发展需要,公司于 2025 年 5 月 9 日召开第八届 董事会第二十一次临时会议,审议通过了关于向江西银行南昌高新支行相关授信 额度事项,同意公司向江西银行南昌高新支行申请人民币 15,600 万元(敞口类 额度)银行综合授信额度,本次会议审议通过的授信额度事项期限为公司第八届 董事会第二十一次临时会议决议签署之日起至 2025 年年度股东大会召开之日止 有效。本次申请人民币 15,600 万元银行综合授信额度后,公司 2025 年可向银行 等金融机构申请综合授信总额度不超过人民币 519,100 万元。具体情况如下: | | | | 单位:万元 | | | --- | --- | --- | --- | --- | | 序号 | 银行名称 | 议案审议前授 | | 议案审议后 | | ...
易德龙: 苏州易德龙科技股份有限公司2024年年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-09 08:45
Core Viewpoint - The company is preparing for its 2024 Annual General Meeting (AGM) scheduled for May 16, 2025, to discuss various proposals including financial reports, profit distribution, and the appointment of auditors [1][2][3]. Group 1: Meeting Agenda and Procedures - The AGM will include the introduction of shareholders, voting methods, and the review of multiple proposals [1][2]. - Shareholders have the right to speak and ask questions during the meeting, with a requirement to register in advance [2][3]. - Voting will be conducted both on-site and via the Shanghai Stock Exchange's online voting system, with specific time slots designated for each [3][4]. Group 2: Financial Reports and Proposals - The board will present the 2024 Annual Work Report and the Supervisory Board's Work Report for shareholder approval [5][6]. - The company achieved a net profit of CNY 184.15 million in 2024, proposing a cash dividend of CNY 10.00 per 10 shares, totaling CNY 160.44 million, which represents 87.13% of the net profit [7][8]. - The company plans to renew its audit engagement with Rongcheng Accounting Firm for the 2025 fiscal year, with audit fees set at CNY 900,000 [8][9]. Group 3: Management Compensation - The actual salary of the Chairman for 2024 is reported at CNY 7.75 million, while total compensation for senior management amounts to CNY 8.88 million [9][10]. - Independent directors received a total of CNY 285,800 in allowances for the year [10]. Group 4: Guarantees and Financing - The company intends to provide guarantees for its wholly-owned subsidiary in Mexico, ETRON-ELB S. DE R.L. DE C.V., for a bank credit line of CNY 2 million [12][13]. - The subsidiary's financial status shows total assets of CNY 4.20 million and liabilities of CNY 6.39 million as of Q1 2025, indicating a negative net asset position [13]. Group 5: Governance and Regulatory Compliance - The company plans to amend its Articles of Association and governance rules to comply with new regulations from the China Securities Regulatory Commission [14].
浙江双元科技股份有限公司 2024年度募集资金存放与实际使用情况的专项报告
Zheng Quan Ri Bao· 2025-04-29 11:18
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688623 证券简称:双元科技 公告编号:2025-009 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创 板上市公司自律监管指引第1号——规范运作》《上海证券交易所科创板股票上市规则》等有关法律、 法规及相关文件的规定,浙江双元科技股份有限公司(以下简称"公司")就2024年度募集资金存放与实 际使用情况专项报告说明如下: 本公司经中国证券监督管理委员会《关于同意浙江双元科技股份有限公司首次公开发行股票注册的批 复》(证监许可[2023]803号)同意注册,由主承销商民生证券股份有限公司通过上海证券交易所系统 采用公开发行方式,向社会公开发行了人民币普通股(A股)股票1,478.57万股,发行价为每股人民币 125.88元,共计募集资金总额为人民币186,122.39万元,扣除券商承销佣金及保荐费16,871.92万元(不 含前期已预付的保荐费用200.00万元)后,主 ...
冠农股份: 新疆冠农股份有限公司第七届监事会第三十六次会议决议公告
Zheng Quan Zhi Xing· 2025-04-02 13:42
Group 1 - The supervisory board of Xinjiang Guannong Co., Ltd. held its 36th meeting, where all proposals were approved unanimously with no votes against or abstentions [1] - The meeting was conducted in accordance with the Company Law and the company's articles of association, with proper notification sent on March 22, 2025 [1][2] - The meeting took place on April 2, 2025, at the company's headquarters in Korla, Xinjiang [1] Group 2 - The supervisory board approved the 2024 annual work report, which will be submitted to the 2024 annual general meeting for review [2] - The board approved a proposal for asset disposal and impairment for 2024, totaling 243.92 million yuan, which will reduce the company's profit by the same amount [2] - The company will recognize credit impairment of 12.83 million yuan and asset impairment of 212.14 million yuan, along with goodwill impairment of 9.03 million yuan [2] Group 3 - The 2024 annual financial settlement report was approved, showing a net profit attributable to the parent company of 204.60 million yuan, a decrease of 71.58% compared to the previous year [2][3] - The profit distribution plan for 2024 and the mid-term dividend plan for 2025 were approved, emphasizing the company's commitment to long-term shareholder interests [3][4] Group 4 - The supervisory board approved the 2024 annual report and its summary, confirming that it accurately reflects the company's financial status and operational results [6] - The internal control evaluation and audit reports for 2024 were also approved, indicating compliance with relevant regulations [5] Group 5 - The board approved a proposal to apply for a total bank credit limit of 2 billion yuan from 15 financial institutions for the year 2025 [7] - The company will use up to 500 million yuan of idle funds for entrusted wealth management in 2025, focusing on low-risk financial products [8] Group 6 - The board approved the expected daily related transactions for 2025 and the investment in a seed industry innovation project not exceeding 27.31 million yuan [8] - A technical transformation investment plan for 2025 was approved, with a budget of up to 57.88 million yuan to enhance production efficiency and quality [9]
辰欣药业: 辰欣药业股份有限公司第五届监事会第七次会议决议公告
Zheng Quan Zhi Xing· 2025-04-01 10:12
Meeting Overview - The seventh meeting of the fifth Supervisory Board of the company was held on April 1, 2025, with all procedures complying with relevant laws and regulations [1][2] - The meeting was chaired by Mr. Zhao Enlong, with three supervisors present [1] Resolutions Passed - The Supervisory Board approved the establishment of a Market Value Management System to enhance the company's market value management practices and protect the rights of investors [2] - The company plans to apply for a comprehensive credit limit of up to RMB 1.5 billion from banks to supplement working capital, with the authorization for management to handle specific financing matters [3] - The company intends to use idle funds for entrusted wealth management and securities investment, with a total limit of up to RMB 2.5 billion, including RMB 1.9 billion for entrusted wealth management and RMB 600 million for securities investment [4]
海王生物: 第九届董事局第二十二次会议决议公告
Zheng Quan Zhi Xing· 2025-03-31 10:07
证券代码:000078 证券简称:海王生物 公告编号:2025-007 深圳市海王生物工程股份有限公司 本公司及董事局全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 一、董事局会议召开情况 深圳市海王生物工程股份有限公司(以下简称"公司"或"本公司")第九届董 事局第二十二次会议的通知于2025年3月27日发出,并于2025年3月31日以通讯会 议的形式召开会议。会议应参与表决董事9人,实际参与表决董事9人。会议的召 开和表决程序符合《公司法》和《公司章程》的规定。 二、董事局会议审议情况 经与会董事审议,会议通过了以下议案: (一)审议通过了《关于 2025 年度提供财务资助的议案》 具体内容详见公司于本公告日在《证券时报》《中国证券报》《上海证券 报》《证券日报》及巨潮资讯网上刊登的《关于 2025 年度提供财务资助的公 告》。 本议案尚需提交公司股东大会审议。 表决结果:9 票同意,0 票反对,0 票弃权。 具体内容详见公司于本公告日在《证券时报》《中国证券报》《上海证券 报》《证券日报》及巨潮资讯网上刊登的《关于担保延续构成对外担保的公 告》。 本议案尚需提交公司股 ...
磁谷科技: 第二届董事会第二十次会议决议公告
Zheng Quan Zhi Xing· 2025-03-28 11:25
Group 1 - The company held its 20th meeting of the second board on March 21, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1] - The board approved the proposal to use up to RMB 150 million of idle funds for entrusted wealth management in 2025, focusing on low-risk, high-security, and good liquidity investment products [1][2] - The board also approved a proposal to apply for a comprehensive credit limit from banks for 2025, allowing for various credit types with a total limit not exceeding RMB 150 million, which can be reused within the validity period [2]
大博医疗: 第三届董事会第十五次会议决议公告
Zheng Quan Zhi Xing· 2025-03-24 09:12
Core Points - The company held its 15th meeting of the third board of directors on March 24, 2025, where several key resolutions were passed [1][2][4] Group 1: Board Resolutions - The board approved the proposal to supplement independent directors, nominating Wei Zhihua and Lin Hongzhen as candidates [2][3] - The board approved a proposal to apply for a comprehensive credit limit of up to 1.9 billion RMB from financial institutions to support business operations and expansion [3][4] - The board authorized the chairman to handle the credit application and sign relevant contracts [4] - The board approved the use of up to 2 billion RMB of temporarily idle self-owned funds for cash management, allowing investment in high-security, liquid financial products [5] - The board passed a proposal regarding the equity of a subsidiary in which major shareholders are involved, with related directors abstaining from the vote [6] Group 2: Upcoming Meetings - The board proposed to hold the first temporary shareholders' meeting of 2025 on April 9, 2025, to review the submitted proposals [6]
科林电气(603050) - 科林电气 2024年度股东大会会议材料
2025-02-27 09:15
石家庄科林电气股份有限公司 2024 年年度股东大会 会议材料 证券简称:科林电气 证券代码:603050 石家庄科林电气股份有限公司 2024 年度股东大会 会议材料 2025 年 3 月 17 日 二、参会股东或股东代表应严格按照本次会议通知所记载的会议登记方法及时 全面的办理会议登记手续及有关事宜。 三、出席会议的股东或股东代表依法享有发言权、表决权等各项权利,并履行 法定义务和遵守相关规则。大会召开期间,股东事先准备发言的,应当在办理会议 登记手续时提出,股东要求临时发言或就有关问题提出质询的应当举手示意,经大 会主持人许可后方可进行。有多名股东同时要求发言的,大会主持人将按照其持有 股份由多到少的顺序安排发言。股东不得无故中断大会议程要求发言。 四、股东或股东代表提出的问题,如与本次股东大会议题无关或将泄露公司商 业秘密或有损公司、股东利益的,大会主持人或相关负责人有权不予回答。 1 石家庄科林电气股份有限公司 2024 年年度股东大会 会议材料 目 录 | 议案一:审议《关于 年度董事会工作报告的议案》 | 2024 | | 6 | | --- | --- | --- | --- | | 议案二: ...